Boston Scientific Corp. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.
Boston Scientific Corp. (BSX) shares fell 1.55% to $68.55 on a poor trading day, marking its third consecutive loss. The stock is 37.40% below its 52-week high of $109.50. Despite the decline, BSX outperformed competitors like Abbott Laboratories, Medtronic PLC, and Stryker Corp., which saw larger losses. Trading volume was 12.4 million, below the 50-day average of 15.3 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments